4-(2-(4-(tert-Butoxycarbonyl)piperazin-1-yl)ethoxy)-3-fluorophenylboronic acid
98%
- Product Code: 90332
CAS:
1704064-14-1
| Molecular Weight: | 368.22 g./mol | Molecular Formula: | C₁₇H₂₆BFN₂O₅ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD28400177 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8°C |
Product Description:
This compound is primarily utilized in organic synthesis and pharmaceutical research. It serves as a key intermediate in the development of biologically active molecules, particularly in the synthesis of protease inhibitors and other therapeutic agents. The boronic acid group enables its use in Suzuki-Miyaura cross-coupling reactions, a widely employed method for forming carbon-carbon bonds in drug discovery. The tert-butoxycarbonyl (Boc) protecting group on the piperazine moiety allows for selective deprotection and further functionalization, making it valuable in constructing complex molecular architectures. Its applications are particularly relevant in medicinal chemistry for designing and optimizing drug candidates targeting various diseases.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.500 | 10-20 days | ฿35,300.00 |
+
-
|
4-(2-(4-(tert-Butoxycarbonyl)piperazin-1-yl)ethoxy)-3-fluorophenylboronic acid
This compound is primarily utilized in organic synthesis and pharmaceutical research. It serves as a key intermediate in the development of biologically active molecules, particularly in the synthesis of protease inhibitors and other therapeutic agents. The boronic acid group enables its use in Suzuki-Miyaura cross-coupling reactions, a widely employed method for forming carbon-carbon bonds in drug discovery. The tert-butoxycarbonyl (Boc) protecting group on the piperazine moiety allows for selective deprotection and further functionalization, making it valuable in constructing complex molecular architectures. Its applications are particularly relevant in medicinal chemistry for designing and optimizing drug candidates targeting various diseases.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :